What are the risks and considerations for using Total Parenteral Nutrition (TPN)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Total Parenteral Nutrition (TPN) should be used with caution due to its significant risks, including catheter-related complications, metabolic complications, and gut mucosal atrophy, and should only be initiated when enteral nutrition is impossible or insufficient, with careful patient selection and monitoring. The primary risks associated with TPN include catheter-related complications such as infection, thrombosis, pneumothorax during insertion, and mechanical problems like occlusion or displacement, as well as metabolic complications including hyperglycemia, electrolyte imbalances (particularly potassium, phosphate, and magnesium), refeeding syndrome in malnourished patients, and liver dysfunction that may progress to cholestasis or steatosis with prolonged use 1.

To minimize these risks, TPN should be initiated with careful consideration of the patient's nutritional needs and underlying health conditions. Regular laboratory testing is essential, including daily glucose checks initially, and frequent electrolyte, liver function, and triglyceride monitoring 1. Strict aseptic technique during catheter care is crucial to prevent infections. Gradual initiation of TPN (starting at 50-75% of goal rate) helps prevent refeeding syndrome, particularly in severely malnourished patients who require additional phosphate, potassium, and magnesium supplementation 1.

Some key considerations for TPN administration include:

  • Providing 25 non-protein kcal/kg per day, increasing to no more than 30 kcal/kg per day, with reductions for patients with systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS) 1
  • Monitoring for signs of overfeeding, such as hyperglycemia, hyperlipidemia, and hepatic dysfunction, and adjusting the TPN regimen accordingly 1
  • Maintaining some enteral nutrition alongside TPN, whenever possible, to preserve gut integrity and facilitate transition to enteral feeding as soon as feasible 1
  • Paying close attention to fluid and electrolyte balance, particularly in patients with acute pancreatitis or other conditions that may affect these parameters 1

By carefully weighing the risks and benefits of TPN and taking steps to minimize its complications, healthcare providers can optimize patient outcomes and improve quality of life for those requiring this form of nutrition support.

From the Research

Risks of Total Parenteral Nutrition (TPN)

  • TPN is a life-saving modality, but it also carries risks for potentially life-threatening complications, including central line-associated bloodstream infections (CLABSIs) 2, 3, 4.
  • The risk of CLABSIs is particularly high in patients receiving TPN, with studies showing that TPN is an independent risk factor for developing CLABSIs 3, 4.
  • Other risk factors for CLABSIs in patients receiving TPN include intensive care unit stay, renal disease, and immunodeficiency 4.
  • Overfeeding, defined as greater than 30 kcal/kg/day, is also associated with an increased risk of CLABSIs in patients receiving TPN 5.
  • Proper administration techniques, including careful selection of candidates, individualizing formulas, and monitoring response to therapy, are crucial to minimizing complications associated with TPN 2, 6.

Considerations for Using TPN

  • Comprehensive management of patients receiving TPN is essential to promote optimal outcomes and minimize complications 2.
  • A collaborative, multidisciplinary approach to TPN therapy is recommended, involving nurses, physicians, and other healthcare professionals 2, 6.
  • Electronic medical records can be useful in identifying risk factors for CLABSIs and assessing the association between CLABSI and TPN administration, but may have limitations due to free-text data entry 4.
  • Further research is needed to identify effective strategies to reduce rates of CLABSIs among patients receiving TPN 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Parenteral nutrition: risks, complications, and management.

Journal of infusion nursing : the official publication of the Infusion Nurses Society, 2012

Research

Parenteral nutrition.

The Nursing clinics of North America, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.